Abonnement à la biblothèque: Guest
Critical Reviews™ in Oncogenesis

Publication de 4  numéros par an

ISSN Imprimer: 0893-9675

ISSN En ligne: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Recent Developments in the Molecular Genetic Understanding of Breast Cancer

Volume 5, Numéro 2-3, 1994, pp. 247-270
DOI: 10.1615/CritRevOncog.v5.i2-3.70
Get accessGet access

RÉSUMÉ

The molecular genetic characterization of breast cancer has implicated or identified the involvement of at least 10 distinct gene alterations in the genesis or progression of this disease. The genes involved fall into three distinct classes, possibly reflecting their particular function in the tumorigenic process. First, there is a class of genes that is being amplified to various levels in clinically manifest breast cancer, most conspicuously c-neu, c-myc, and cyclin D1. Second, an as-yet unknown number of genes are targets for loss of heterozygosity or allelic imbalance events on a number of different chromosomes. Presumably, this reflects the presence of tumor suppressor genes located on chromosomes 3p, 6q, 16q, 17, and possibly a few additional chromosomes. Finally, at least three genes are implicated to confer heritable predisposition to breast cancer. These include the p53 oncogene on 17p, an as yet unknown gene on 17q, and at least one locus outside these regions. While a number of presently unknown genes will soon be identified and cloned, it is becoming evident from genetic mapping studies that the complexity of gene involvement in breast cancer has not yet seen its very limits. A comprehensive multidisciplinary molecular profiling of a large series of tumors of various histological subtypes may aid in understanding how the different genes may cooperate to cause breast cancer.

CITÉ PAR
  1. Imyanitov Evgeny N., Suspitsin Evgeny N., Grigoriev Maxim Yu., Togo Alexandr V., Kuligina Ekatherina Sh., Belogubova Evgeniya V., Pozharisski Kazymir M., Turkevich Elena A., Rodriquez Carmen, Cornelisse Cees J., Hanson Kaido P., Theillet Charles, Concordance of allelic imbalance profiles in synchronous and metachronous bilateral breast carcinomas, International Journal of Cancer, 100, 5, 2002. Crossref

  2. Brown Melissa A., , 36, 1997. Crossref

  3. Piao Zhe, Lee Kyong Sik, Kim Hoguen, Perucho Manuel, Malkhosyan Sergei, Identification of novel deletion regions on chromosome arms 2q and 6p in breast carcinomas by amplotype analysis, Genes, Chromosomes and Cancer, 30, 2, 2001. Crossref

  4. Fujii Hiroaki, Zhou Weibo, Gabrielson Edward, Detection of frequent allelic loss of 6q23–q25.2 in microdissected human breast cancer tissues, Genes, Chromosomes and Cancer, 16, 1, 1996. Crossref

  5. Kuukasjärvi Tuula, Tanner Minna, Pennanen Sari, Karhu Ritva, Visakorpi Tapio, Isola Jorma, Optimizing DOP-PCR for universal amplification of small DNA samples in comparative genomic hybridization, Genes, Chromosomes and Cancer, 18, 2, 1997. Crossref

  6. McKenzie Katherine E., Armstrong Barbara A., Chen Ying, Nagarajan Mahalakshmi, Aldaz C. Marcelo, Sukumar Saraswati, Alterations in the Ha-ras-1 and thep53 pathway genes in the progression ofN-methyl-N-nitrosourea–induced rat mammary tumors, Molecular Carcinogenesis, 20, 2, 1997. Crossref

  7. Kirschmann Dawn A., Seftor Elisabeth A., Nieva Daniel R.C., Mariano Elpidio A., Hendrix Mary J.C., Differentially expressed genes associated with the metastatic phenotype in breast cancer, Breast Cancer Research and Treatment, 55, 2, 1999. Crossref

  8. Tsukamoto Tetsuya, Huang Tony, Guzman Raphael C., Chen Xiaoyan, Pascual Rhett V., Kitamura Toshio, Nandi Satyabrata, Isolation of Oncogenes from Rat Mammary Tumors by a Highly Efficient Retrovirus Expression Cloning System, Biochemical and Biophysical Research Communications, 265, 1, 1999. Crossref

  9. Slovak Marilyn L., Wolman Sandra R., Breast Cancer Cytogenetics: Clues to Genetic Complexity of the Disease, The Breast Journal, 2, 1, 1996. Crossref

  10. Slovak Marilyn L., Wolman Sandra R., Breast Cancer Cytogenetics: Clues to Genetic Complexity of the Disease, The Breast Journal, 2, 2, 1996. Crossref

  11. Chen Shou‐Tung, Yu Shi‐Yau, Tsai Matty, Yeh Kun‐Tu, Wang Jyh‐Chwan, Kao Min‐Chih, Shih Mu‐Ching, Chang Jan‐Gowth, Mutation analysis of the putative tumor suppression gene PTEN/MMAC1 in sporadic breast cancer, Breast Cancer Research and Treatment, 55, 1, 1999. Crossref

  12. Azorsa David O., Cunliffe Heather E., Meltzer Paul S., Association of steroid receptor coactivator AIB1 with estrogen receptor-α in breast cancer cells, Breast Cancer Research and Treatment, 70, 2, 2001. Crossref

  13. Leighton Ximena, Srikantan Vasanta, Pollard Harvey B, Sukumar Saraswati, Srivastava Meera, Significant allelic loss of ANX7region (10q21) in hormone receptor negative breast carcinomas, Cancer Letters, 210, 2, 2004. Crossref

  14. Dueñas-González A., Abad-Hernández M.M., García-Mata J., Paz-Bouza J.I., Cruz-Hernández J.J., González-Sarmiento R., Analysis of nm23-H1 expression in breast cancer. Correlation with p53 expression and clinicopathologic findings, Cancer Letters, 101, 2, 1996. Crossref

  15. Ghosh A.K., Grigorieva I., Steele R., Hoover R.G., Ray R.B., PTEN transcriptionally modulates c-myc gene expression in human breast carcinoma cells and is involved in cell growth regulation, Gene, 235, 1-2, 1999. Crossref

  16. Hamann U., Costa S.D., Götte K., Huober J., Solomayer E.-F., Kaufmann M., Bastertt G., Komitowski D., Allelic imbalance in three distinct regions on chromosome 17q in sporadic breast cancer correlates with prognostic parameters, The Breast, 6, 1, 1997. Crossref

  17. Faustino-Rocha Ana I., Ferreira Rita, Oliveira Paula A., Gama Adelina, Ginja Mário, N-Methyl-N-nitrosourea as a mammary carcinogenic agent, Tumor Biology, 36, 12, 2015. Crossref

  18. Goyal S., Bennett P., Sweetland H.M., Monypenny I.J., Webster D.J.T., Mansel R.E., Are surgeons effective counsellors for women with a family history of breast cancer?, European Journal of Surgical Oncology (EJSO), 28, 5, 2002. Crossref

  19. Chisholm Karen M., Aubert Sarah D., Freese Krister P., Zakian Virginia A., King Mary-Claire, Welcsh Piri L., Schönbach Christian, A Genomewide Screen for Suppressors of Alu-Mediated Rearrangements Reveals a Role for PIF1, PLoS ONE, 7, 2, 2012. Crossref

  20. Korkola James E, Wood Geoffrey A, Archer Michael C, Cyclin D1expression during rat mammary tumor development and its potential role in the resistance of the Copenhagen rat, Breast Cancer Research, 1, 1, 1999. Crossref

  21. Piao Zhe, Malkhosyan Sergei R., Frequent loss Xq25 on the inactive X chromosome in primary breast carcinomas is associated with tumor grade and axillary lymph node metastasis, Genes, Chromosomes and Cancer, 33, 3, 2002. Crossref

  22. Russell A J, Sibbald J, Haak H, Keith W N, McNicol A M, Increasing genome instability in adrenocortical carcinoma progression with involvement of chromosomes 3, 9 and X at the adenoma stage, British Journal of Cancer, 81, 4, 1999. Crossref

  23. Elzagheid A, Kuopio T, Pyrhönen S, Collan Y, Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future?, Diagnostic Pathology, 1, 1, 2006. Crossref

  24. Slovak Marilyn L., Breast Tumor Cytogenetic Markers, in Human Cytogenetic Cancer Markers, 1997. Crossref

  25. Chen Shou-Tung, Choo Kong-Bung, Hou Ming-Feng, Yeh Kun-Tu, Kuo Shou-Jen, Chang Jan-Gowth, Deregulated expression of the PER1 , PER2 and PER3 genes in breast cancers, Carcinogenesis, 26, 7, 2005. Crossref

  26. Veronese Maria Luisa, Bullrich Florencia, Croce Carlo M., Oncogenes and Mammary Carcinogenesis, in Endocrinology of Breast Cancer, 1999. Crossref

  27. Bennett L. Michelle, Mcallister Kimberly A., Ward Toni, Malphurs Jason, Collins N. Keith, Seely John C., Davis Barbara J., Wiseman Roger W., Mammary Tumor Induction and Premature Ovarian Failure in ApcMin Mice Are Not Enhanced by Brca2 Defi ciency, Toxicologic Pathology, 29, 1, 2001. Crossref

  28. Zhang Hao, Kuang Shao-Qing, Liao Lan, Zhou Suoling, Xu Jianming, Haploid Inactivation of the Amplified-in-Breast Cancer 3 Coactivator Reduces the Inhibitory Effect of Peroxisome Proliferator-Activated Receptor γ and Retinoid X Receptor on Cell Proliferation and Accelerates Polyoma Middle-T Antigen-Induced Mammary Tumorigenesis in Mice, Cancer Research, 64, 19, 2004. Crossref

  29. Zhu Yijun, Qi Chao, Jain Sanjay, Le Beau Michelle M., Espinosa Rafael, Atkins G. Brandon, Lazar Mitchell A., Yeldandi Anjana V., Rao M. Sambasiva, Reddy Janardan K., Amplification and overexpression of peroxisome proliferatoractivated receptor binding protein ( PBP/PPARBP ) gene in breast cancer , Proceedings of the National Academy of Sciences, 96, 19, 1999. Crossref

  30. Toyama Tatsuya, Iwase Hirotaka, Watson Peter, Muzik Huong, Saettler Elizabeth, Magliocco Anthony, DiFrancesco Lisa, Forsyth Peter, Garkavtsev Igor, Kobayashi Shunzo, Riabowol Karl, Suppression of ING1 expression in sporadic breast cancer, Oncogene, 18, 37, 1999. Crossref

  31. Kanda Tatsuo, Raychoudhuri Amit, Steele Robert, Sagartz John E., West Cheri, Ray Ratna B., MBP-1 Inhibits Breast Cancer Growth and Metastasis in Immunocompetent Mice, Cancer Research, 69, 24, 2009. Crossref

  32. Anzick Sarah L., Kononen Juha, Walker Robert L., Azorsa David O., Tanner Minna M., Guan Xin-Yuan, Sauter Guido, Kallioniemi Olli-P., Trent Jeffrey M., Meltzer Paul S., AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian Cancer, Science, 277, 5328, 1997. Crossref

  33. Wang Yian, Hu Lan, Yao Ruisheng, Wang Min, Crist Keith A, Grubbs Clinton J, Johanning Gary L, Lubet Ronald A, You Ming, Altered gene expression profile in chemically induced rat mammary adenocarcinomas and its modulation by an aromatase inhibitor, Oncogene, 20, 53, 2001. Crossref

Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections Prix et politiques d'abonnement Begell House Contactez-nous Language English 中文 Русский Português German French Spain